Neurol. praxi. 2008;9(1):30-32

Vyšetření čichu a jeho význam pro diagnostiku neurodegenerativních onemocnění

MUDr. Hana Magerová1, MUDr. Jan Laczó, MUDr. Martin Vyhnálek2, as. MUDr. Jakub Hort, Ph.D.2, doc. MUDr. Martin Bojar, CSc.2
1 Centrum pro poruchy kognitivních funkcí Neurologická klinika 2. LF UK, Praha
2 Neurologická klinika 2. LF UK a FN Motol, Praha

Porucha čichu může být jedním z prvních projevů neurodegenerativního onemocnění mozku. Byla popsána a podrobně studována u Parkinsonovy choroby i u dalších neurodegenerativních onemocnění. V poslední době se dostává do popředí zájmu jako jeden z časných markerů Alzheimerovy choroby, který lze využít i v diferenciální diagnostice. Autoři předkládají přehledný článek pojednávající o specificích čichového postižení u jednotlivých chorob, čichových testech a uplatnění vyšetření čichu v diagnostice neurodegenerativních onemocnění.

Keywords: čich, kognitivní porucha, neurodegenerativní onemocnění

Published: March 15, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Magerová H, Laczó J, Vyhnálek M, Hort J, Bojar M. Vyšetření čichu a jeho význam pro diagnostiku neurodegenerativních onemocnění. Neurol. praxi. 2008;9(1):30-32.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ansari KA, Johnson AJ. Olfactory function in patients with Parkinson's disease. Chronic Dis 1975; 28: 493-497. Go to original source... Go to PubMed...
    2. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991; 82: 239-259. Go to original source... Go to PubMed...
    3. Devanand DP, Michaels-Marston KS, Liu X et al. Olfactory deficits in patiens with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000; 157: 1399-1405. Go to original source... Go to PubMed...
    4. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration 1995; 4: 93-97. Go to original source... Go to PubMed...
    5. Duff K, McCaffrey RJ, Solomon GS. The Pocket Smell Test: Successfully discriminating probable Alzheimer's dementia from vascular dementia and major depression. J Neuropsychiatry Clin Neurosci 2002; 14: 197-201. Go to original source... Go to PubMed...
    6. Gomez-Tortosa E, Newell K, Irizarry MC et al. Clinical and quantitative pathologic correlates of dementi with Lewy bodies. Neurology 1999; 53: 1284-1291. Go to original source... Go to PubMed...
    7. Graves AB, Bowen JD, Rajaram L, McCormic WC, McCurry SM, Schellenberg GD, Larson EB. Impaired olfaction as a marker for cognitive decline: imteraction with apolipoprotein ?4 status. Neurology 1999; 53: 1480-1487. Go to original source... Go to PubMed...
    8. Hawkes CH, Shephard BC. Selective anosmia in Parkinson's disease? Lancet 1993; 341: 435-436. Go to original source...
    9. Koss E, Weiffenbach JM, Haxby JV, Friedland MD. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988; 38: 1228-1232. Go to original source... Go to PubMed...
    10. Lehrner JP, Brucke T, Kryspin-Exner I et al. Impaired olfactory function in Parkinson's disease. Lancet 345, 1054-1055. Go to original source... Go to PubMed...
    11. Luzzi S, Snowden JS, Neary D et al. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 2007; 45: 1823-1831. Go to original source... Go to PubMed...
    12. McShane RH, Nagy Z, Esiri MM et al. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001; 70: 739-743. Go to original source... Go to PubMed...
    13. Murphy C, Nordin S, Acosta L. Odor learning, recall, and recognition memory in young and elderly adults. Neuropsychology 1997; 11: 126-137. Go to original source... Go to PubMed...
    14. Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with odor identification deficits in nondemented older person, Ann. N.Y. Acad. Sci., 1998; 855: 744-750. Go to original source... Go to PubMed...
    15. Quinn NP, Rossor MN, Marsden CD. Olfactory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987; 50: 88-89. Go to original source... Go to PubMed...
    16. Roth J, Radil, Růžička E et al. Apomorphine does not influence olfactory thresholds in Parkinson's disease, Funct Neurol, 1998; 13(2): 99-103.
    17. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in Alzheimer's disease, Am J Psychiatry 1991; 148: 357-360. Go to original source... Go to PubMed...
    18. Stern MB, Doty RL, Dotti M et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994; 44: 266-268. Go to original source... Go to PubMed...
    19. Tissingh G, Berendse HW, Bergmans P et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001; 16: 41-46. Go to original source... Go to PubMed...
    20. Westervelt HJ, Stern RA, Remont G. Odor Identification Deficits in Diffuse Lewy Body Disease, Cognitive and Behavioral Neurology, 2003; 16: 93-99. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.